v3.23.1
STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Preferred Stock
Series m Preferred Stock
Preferred Stock
Series m-1 Preferred Stock
Preferred Stock
Series m-2 Preferred Stock
Preferred Stock
Series m-3 Preferred Stock
Preferred Stock
Series m-4 Preferred Stock
Preferred Stock
Series S Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in-capital
Accumulative Deficit
Total
Balance as of beginning at Dec. 31, 2020 $ 13,866   $ 4,982 $ 46 $ 5,826 $ 27,135 $ 3,865 $ 9,442          
Balance as of beginning (in shares) at Dec. 31, 2020 5,339,215   1,660,756 16,757 1,432,786 3,731,248 8,936,015 4,653,583          
Increase (decrease) in temporary equity                          
Warrants Exercised   $ 1,319                      
Warrants Exercised (in shares)   186,872                      
Issuance of Series s Preferred Stock, net of issuance costs           $ 16,545              
Issuance of Series s Preferred Stock, net of issuance costs (in shares)           1,855,904              
Share conversion to common stock $ (1,985)   $ (1,227)   $ (6,434) $ (13,685) $ (1,202) $ (1,883) $ 6 $ 3 $ 26,407   $ 26,416
Share conversion to common stock (in shares) (764,298)   (409,090)   (1,432,786) (1,881,913) (2,780,451) (927,491) 5,932,533 2,942,197      
Series m-4 accrued dividend         $ 608             $ (608) $ (608)
Balance at the end at Dec. 31, 2021 $ 11,881 $ 1,319 $ 3,755 $ 46   $ 29,995 $ 2,663 $ 7,559          
Balance at the end (in shares) at Dec. 31, 2021 4,574,917 186,872 1,251,666 16,757   3,705,239 6,155,564 3,726,092         19,617,107
Balance as of beginning at Dec. 31, 2020                   $ 10 3,051 (69,246) $ (66,185)
Balance as of beginning (in shares) at Dec. 31, 2020                   10,189,000      
Increase (decrease) in stockholders' equity                          
Stock based compensation                     1,269   1,269
Warrants expired                     14   14
Stock options exercised                     4   $ 4
Stock options exercised (in shares)                 4,396       4,396
Net loss                       (43,843) $ (43,843)
Balance as of end at Dec. 31, 2021                 $ 6 $ 13 30,745 (113,697) $ (82,933)
Balance as of end (in shares) at Dec. 31, 2021                 5,936,929 13,131,197      
Increase (decrease) in temporary equity                          
Share conversion to common stock $ (7,063) $ (1,319) $ (3,275) $ (46)   $ (8,018) $ (1,328) $ (386)          
Share conversion to common stock (in shares) (2,719,589,000) (186,872,000) (1,091,666,000) (16,757,000)   (990,507,000) (3,069,404,000) (190,471,000)          
Balance at the end at Dec. 31, 2022 $ 4,818   $ 480     $ 21,977 $ 1,335 $ 7,173          
Balance at the end (in shares) at Dec. 31, 2022 1,855,328,000   160,000,000     2,714,732,000 3,086,160,000 3,535,621,000         11,351,841
Increase (decrease) in stockholders' equity                          
Stock based compensation                     3,539   $ 3,539
Warrants exercised                     370   370
Warrants exercised (in shares)                 156,483,000        
Conversion of debt obligations to Class A Common Stock                 $ 7   16,004   16,011
Conversion of debt obligations to Class A Common Stock (in shares)                 6,513,385,000        
Stock options exercised                     551   $ 551
Stock options exercised (in shares)                 370,235,000 25,000,000     395,235
Offering proceeds net of issuance costs                 $ 2   19,623   $ 19,625
Offering proceeds, net of issuance costs (shares)                 2,236,619,000        
Shares issued for consulting services                     653   653
Shares issued for consulting services (in shares)                 236,567,000        
Proceeds from equity sale, net of issuance costs                 $ 1   2,878   2,879
Proceeds from equity sale, net of issuance costs (in shares)                 1,307,950,000        
Share conversion costs                     (74)   (74)
Share conversion to common stock                 $ 12 $ (3) 21,427   21,436
Share conversion to common stock (in shares)                 11,271,070,000 (2,836,313,000)      
Net loss                       (25,643) (25,643)
Balance as of end at Dec. 31, 2022                 $ 28 $ 10 $ 95,716 $ (139,340) $ (43,586)
Balance as of end (in shares) at Dec. 31, 2022                 28,029,238,000 10,319,884,000